Previous Article | Next Article ![]()
Journal of Bacteriology, March 2009, p. 1722-1724, Vol. 191, No. 5
0021-9193/09/$08.00+0 doi:10.1128/JB.01573-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Laboratoire de Génétique et de Physiologie Bactérienne, Institut de Biologie et de Médecine Moléculaires, Faculté des Sciences, Université Libre de Bruxelles, 12 rue des Professeurs Jeener et Brachet, B:6041 Gosselies, Belgium
Received 5 November 2008/ Accepted 10 December 2008
|
|
|---|
|
|
|---|
Homologues of csrA have been identified, and their role in several bacterial species has been studied (for a review, see reference 15). These csrA homologues share regulatory networks with those identified in E. coli, such as motility (17) and biofilm formation (8). These homologues also appear to regulate other processes, such as virulence in Salmonella enterica, Legionella pneumophila, Helicobacter pylori, Proteus mirabilis, and Yersinia pseudotuberculosis (3, 9, 13, 17, 24); quorum sensing in Erwinia carotovora and Vibrio cholerae (5, 16); and oxidative stress resistance in Campylobacter jejuni (8).
In E. coli, the csrA gene was identified by transposon mutagenesis in a screen for mutants with altered glycogen accumulation. The kanamycin transposon insertion site is located at codon 51 in the csrA coding sequence (which encodes a protein of 61 amino acids). In addition to an increased glycogen accumulation, the csrA::kan mutant is affected for motility, biofilm formation, and glycolysis (2, 19, 21, 22, 28). In association with an rpoS defective mutation, the csrA::kan mutation led to an extended lag phase upon growth on acetate (27). Suppressor mutations restoring growth of the double mutant on acetate were mapped in the glg locus (27). This indicates that the growth defect presented by the double csrA::kan rpoS mutant was associated with a high level of glycogen accumulation (27). Acetate sensitivity appears to require both the csrA::kan and the rpoS mutations since single mutants were not sensitive to acetate and did not evolve suppressor mutations (27).
The E. coli csrA gene is essential under certain growth conditions.
In an attempt to construct a csrA deletion mutant of E. coli, large series of homologous recombination experiments were carried out with the DJ624 strain (MG1655 lacX74 malP::lacIq) (12) to replace the csrA open reading frame (ORF) with a chloramphenicol resistance cassette (6). Despite many attempts under various conditions, no deletion mutants were obtained, suggesting that csrA is essential for growth. To test this hypothesis, various rescue plasmids were constructed. The csrA gene was cloned in the pBAD33 (11) and pKK223-3 (4) expression vectors. The expression of the rescue copy of csrA was induced in LB medium by the addition of arabinose (0.4%) and isopropyl β-D-1-thiogalactopyranoside (IPTG) (1 mM). These constructs were checked by sequencing, and their ability to complement a csrA::kan mutation was tested. Using these plasmids as csrA rescue copy, attempts to delete csrA in DJ624 were not successful, indicating that high expression levels of CsrA might be deleterious under these conditions. To bypass this problem, the csrA gene was cloned in the low-copy-number pWSK129 vector under the control of the lac promoter (25). DJ624 was transformed by this construct, and csrA expression was induced by the addition of 0.1 mM IPTG in the culture medium. Under these conditions, csrA deletion mutants were obtained on LB plates containing chloramphenicol (20 µg/ml) and kanamycin (50 µg/ml) at 37°C (
csrA::cat). The replacement of the csrA ORF with the chloramphenicol resistance cassette was checked by PCR using primers flanking the csrA ORF. The
csrA::cat mutant strain containing the pWSK-csrA plasmid was able to grow in the presence of 0.1 mM IPTG. No growth was observed on LB plates without IPTG, showing that the csrA gene is essential for growth in LB medium (Fig. 1, upper panels).
![]() View larger version (92K): [in a new window] |
FIG. 1. The csrA gene is essential in E. coli. The csrA::cat mutant containing either the pWSK-csrA (upper panels) or the pKK-csrA1-50 (lower panels) plasmids were grown on LB plates containing the appropriate antibiotics with 0.1 mM IPTG (left panels) and without IPTG (right panels).
|
csrA::cat pWSK-csrA pKK-csrA1-50 strain was transformed by the pMLO59 vector, and the resulting transformants were plated on LB plates containing spectinomycin (100 µg/ml), chloramphenicol (20 µg/ml), and 0.1 mM IPTG to induce the expression of the csrA1-50 polypeptide. Transformants were checked for kanamycin sensitivity (loss of the pWSK-csrA plasmid). The
csrA::cat mutant containing the pKK-csrA1-50 plasmid was able to form colonies on LB plates containing 0.1 mM IPTG but not on plates without IPTG (Fig. 1, lower panels), showing that the CsrA1-50 peptide is functional. On IPTG plates, the colonies had an abnormal phenotype (forming heterogeneous and "sticky" colonies). The molecular mechanisms underlying this phenotype are unknown. This phenotype does not appear to be dependent on the CsrA1-50 amount, since it has also been observed at higher IPTG concentrations (data not shown). As the carboxy-terminal part of CsrA (amino acids 51 to 54) is involved in RNA binding (20), the truncated form of CsrA might have a reduced affinity for RNA (another RNA binding site has been mapped in the amino-terminal region of CsrA). This might provide an explanation for the phenotype of the csrA::kan mutant.
An excess of glycogen accumulation impairs the growth of the csrA::cat mutant.
CsrA controls the intracellular carbon flux by positively regulating the glycolysis pathway and negatively regulating the gluconeogenesis pathway and glycogen synthesis (Fig. 2) (22). In the absence of CsrA, glycogen synthesis is strongly favored. Indeed, the csrA::kan insertion mutation resulted in 20-fold-higher levels of glycogen (21). The csrA::cat mutant might thus be unable to direct the carbon flux to the Krebs cycle, because of a reduced glycolysis and an enhanced glycogenesis. To test this hypothesis, the
csrA::cat mutant was plated on Ceria synthetic medium (10) containing amino acids and glycolytic carbon sources. The
csrA::cat mutant was unable to grow on glucose and on fructose-6-phosphate as sole carbon sources (Fig. 3B and C). Interestingly, it was able to grow on pyruvate, which is the carbon source at the junction between glycolysis and the Krebs cycle (Fig. 3D). On fructose-6-phosphate plates, very small colonies appeared after 16 h at 37°C (too small to be seen in Fig. 3C). These data indicate that the early steps of glycolysis are not fully functional in the
csrA::cat mutant. With glucose and fructose-6-phosphate as sole carbon sources, the carbon flux might be essentially directed to glycogen synthesis, thereby impairing glycolysis and the Krebs cycle. We tested whether the deletion of the glgCAP operon, which is involved in the first two steps of glycogen synthesis, would restore the ability to grow on glycolytic carbon sources. The glgCAP operon was deleted in the DJ624 strain by using the method described in reference 6. The csrA::cat deletion was then transduced by P1 in the
glgCAP strain containing the pWSK-csrA plasmid in the presence of 0.1 mM IPTG. Transductants were obtained and checked by PCR with primers flanking the csrA ORF. Interestingly, the double
glgCAP
csrA::cat pWSK-csrA mutant was able to form colonies on LB plates without IPTG (Fig. 3E) as well as on glucose and fructose-6-phosphate plates (Fig. 3F and G), unlike the
csrA::cat pWSK-csrA mutant (Fig. 3A, B, and C). Both strains were able to grow in the presence of pyruvate as the sole carbon source (Fig. 3D and H). Our data show that in the csrA::cat mutant, glycogen synthesis is favored and that glycogen accumulation impairs viability. In the absence of the glycogen synthesis pathway, the carbon flux is most likely redirected to glycolysis and/or pentose phosphate pathways, thereby enabling the Krebs cycle to be functional.
![]() View larger version (13K): [in a new window] |
FIG. 2. CsrA-mediated regulation of the central carbon flux. CsrA positively regulates glycolysis and negatively regulates gluconeogenesis and glycogen synthesis. Negative and positive regulations of target genes are indicated by blocked arrows ( ) and arrows, respectively. Adapted from reference 22.
|
![]() View larger version (61K): [in a new window] |
FIG. 3. Excessive glycogen accumulation in the csrA::cat mutant impairs viability on glycolytic carbon sources. The csrA::cat (left panels) and the csrA::cat glgCAP (right panels) mutants containing the pWSK-csrA plasmid were streaked without IPTG on LB medium (A and E) or on minimal medium containing amino acids, with either glucose (B and F), fructose-6-phosphate (C and G), or pyruvate (D and H) as the sole carbon source.
|
csrA::cat mutant, most likely by forcing the carbon flux to enter glycolysis and the Krebs cycle.
This work was supported by Fonds de la Recherche Scientifique Médicale (3.4510.02), the Fonds Brachet, and the Fondation Van Buuren. J.T. is supported by the Fonds pour la Formation à la Recherche dans l'Industrie et dans l'Agriculture.
Published ahead of print on 19 December 2008. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»